{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:04:49Z","timestamp":1784167489551,"version":"3.55.0"},"reference-count":14,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Polish Society of Allergology","award":["1\/GNB\/2022"],"award-info":[{"award-number":["1\/GNB\/2022"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Inhaled corticosteroids exert broad immunomodulatory effects in patients with chronic airway diseases. However, their direct impact on pulmonary endothelial immune responses and coronavirus-associated receptor expression remains unclear. This study investigated the effects of budesonide on immune responses and the expression of coronavirus entry receptors in human lung microvascular endothelial cells (HMVEC-L). Materials and Methods: HMVEC-L cells were exposed to budesonide (1 ng\/mL), a non-cytotoxic concentration selected based on cell viability assays. The mRNA expression of angiotensin-converting enzyme 2 (ACE2), dipeptidyl peptidase-4 (DPP4), aminopeptidase N (AP-N), intercellular adhesion molecule 1 (ICAM-1), interferon beta (IFN-\u03b2), RANTES\/CCL5, and interleukin-8 (IL-8\/CXCL8) was analyzed using quantitative RT-PCR. The surface expression of ACE2, DPP4, AP-N, and ICAM-1 was assessed using flow cytometry. Secreted IL-8 concentration was measured using ELISA. Results: Budesonide significantly reduced AP-N and DPP4 mRNA expression, accompanied by a decrease in the surface expression of both receptors. ACE2 mRNA expression was transiently reduced, whereas ACE2 surface expression was modestly increased by approximately 5% at 72 h. Budesonide also reduced early ICAM-1 mRNA expression but increased its surface expression at the later time point. Budesonide significantly reduced RANTES\/CCL5 and IL-8\/CXCL8 mRNA expression, with a corresponding decrease in secreted IL-8 concentration, whereas IFN-\u03b2 mRNA expression showed a non-significant statistical decrease. Conclusions: Budesonide directly modulates pulmonary endothelial immune responses and coronavirus-associated receptor expression. These findings indicate that budesonide modulates the expression of coronavirus-associated receptors and basal antiviral and inflammatory mediators in HMVEC-L cells. Because viral binding, entry, replication, and infection were not assessed, these results should be interpreted as evidence of receptor and immune-mediator modulation rather than as demonstrating altered coronavirus susceptibility.<\/jats:p>","DOI":"10.3390\/medicina62071347","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:28:27Z","timestamp":1783927707000},"page":"1347","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of Budesonide on Coronavirus-Associated Receptor and Immune-Mediator Expression in Human Lung Microvascular Endothelial Cells"],"prefix":"10.3390","volume":"62","author":[{"given":"Izabela","family":"\u0141awska","sequence":"first","affiliation":[{"name":"Department of Immunology and Allergy, Medical University of Lodz, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-1074","authenticated-orcid":false,"given":"Adrian","family":"Bekier","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergy, Medical University of Lodz, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8311-9530","authenticated-orcid":false,"given":"Maciej","family":"Cha\u0142ubi\u0144ski","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergy, Medical University of Lodz, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Wardzy\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Immunology and Allergy, Medical University of Lodz, 92-213 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jaip.2017.05.001","article-title":"Asthma exacerbations: Pathogenesis, prevention, and treatment","volume":"5","author":"Castillo","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2020.09.034","article-title":"Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon","volume":"147","author":"Finney","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/rccm.202003-0821OC","article-title":"COVID-19-related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids","volume":"202","author":"Peters","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nri2171","article-title":"Evolving functions of endothelial cells in inflammation","volume":"7","author":"Pober","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41577-020-0343-0","article-title":"COVID-19: The vasculature unleashed","volume":"20","author":"Teuwen","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/all.15251","article-title":"IL-33 prevents the enhancement of AP-N, DPP4, and ACE2 expression induced by rhinovirus HRV16 in the human lung endothelium: Potential implications for coronaviral airway infections","volume":"77","author":"Gulbas","year":"2022","journal-title":"Allergy"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.2010.01199.x","article-title":"Glucocorticosteroids: Current and future directions","volume":"163","author":"Barnes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids--new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41467-018-04574-1","article-title":"Corticosteroid suppression of antiviral immunity increases bacterial loads and mucus production in COPD exacerbations","volume":"9","author":"Singanayagam","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1471-4906(03)00117-0","article-title":"Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response","volume":"24","author":"Muller","year":"2003","journal-title":"Trends Immunol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): A randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/S2213-2600(20)30415-X","article-title":"Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: An observational cohort study using the OpenSAFELY platform","volume":"8","author":"Schultze","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: A national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK","volume":"9","author":"Bloom","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.resinv.2019.12.005","article-title":"Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells","volume":"58","author":"Yamaya","year":"2020","journal-title":"Respir. Investig."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1347\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:35:37Z","timestamp":1784165737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/7\/1347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,12]]},"references-count":14,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medicina62071347"],"URL":"https:\/\/doi.org\/10.3390\/medicina62071347","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,12]]}}}